{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:26:14Z","timestamp":1779931574700,"version":"3.53.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00464-024-10910-y","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T17:01:50Z","timestamp":1717693310000},"page":"3992-3998","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["To wean or not to wean: proton pump inhibitor management after anti-reflux surgery amongst foregut experts"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4932-4829","authenticated-orcid":false,"given":"Michael Johannes","family":"Pfl\u00fcger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa Mae","family":"Coker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda Marie","family":"Zosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina Lynn","family":"Adrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett Colton","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"issue":"6","key":"10910_CR1","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","volume":"63","author":"HB El-Serag","year":"2014","unstructured":"El-Serag HB, Sweet S, Winchester CC, Dent J (2014) Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 63(6):871","journal-title":"Gut"},{"issue":"5","key":"10910_CR2","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cgh.2022.01.025","volume":"20","author":"R Yadlapati","year":"2022","unstructured":"Yadlapati R, Gyawali CP, Pandolfino JE, Participants CGCC (2022) AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review. Clin Gastroenterol Hepatol 20(5):984","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10910_CR3","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1053\/j.gastro.2012.08.002","volume":"143","author":"AF Peery","year":"2012","unstructured":"Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, Gangarosa LM, Thiny MT, Stizenberg K, Morgan DR, Ringel Y, Kim HP, DiBonaventura MD, Carroll CF, Allen JK, Cook SF, Sandler RS, Kappelman MD, Shaheen NJ (2012) Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 143(5):1179","journal-title":"Gastroenterology"},{"issue":"1","key":"10910_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","volume":"117","author":"PO Katz","year":"2022","unstructured":"Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ (2022) ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 117(1):27","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10910_CR5","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1053\/j.gastro.2019.12.014","volume":"158","author":"SD Delshad","year":"2020","unstructured":"Delshad SD, Almario CV, Chey WD, Spiegel BMR (2020) Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms. Gastroenterology 158(5):1250","journal-title":"Gastroenterology"},{"issue":"10","key":"10910_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/MCG.0000000000001518","volume":"55","author":"CW Howden","year":"2021","unstructured":"Howden CW, Manuel M, Taylor D, Jariwala-Parikh K, Tkacz J (2021) Estimate of refractory reflux disease in the United States: economic burden and associated clinical characteristics. J Clin Gastroenterol 55(10):842","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"10910_CR7","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/j.1365-2036.2010.04406.x","volume":"32","author":"H El-Serag","year":"2010","unstructured":"El-Serag H, Becher A, Jones R (2010) Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther 32(6):720","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10910_CR8","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1007\/s00464-021-08625-5","volume":"35","author":"BJ Slater","year":"2021","unstructured":"Slater BJ, Dirks RC, McKinley SK, Ansari MT, Kohn GP, Thosani N, Qumseya B, Billmeier S, Daly S, Crawford C, Anne PE, Hollands C, Palazzo F, Rodriguez N, Train A, Wassenaar E, Walsh D, Pryor AD, Stefanidis D (2021) SAGES guidelines for the surgical treatment of gastroesophageal reflux (GERD). Surg Endosc 35(9):4903\u20134917","journal-title":"Surg Endosc"},{"issue":"4","key":"10910_CR9","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2021.12.247","volume":"162","author":"LE Targownik","year":"2022","unstructured":"Targownik LE, Fisher DA, Saini SD (2022) AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review. Gastroenterology 162(4):1334","journal-title":"Gastroenterology"},{"issue":"5","key":"10910_CR10","first-page":"354","volume":"63","author":"B Farrell","year":"2017","unstructured":"Farrell B, Pottie K, Thompson W, Boghossian T, Pizzola L, Rashid FJ, Rojas-Fernandez C, Walsh K, Welch V, Moayyedi P (2017) Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Phys 63(5):354","journal-title":"Can Fam Phys"},{"issue":"6","key":"10910_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1365-2036.2006.03084.x","volume":"24","author":"E Bjornsson","year":"2006","unstructured":"Bjornsson E, Abrahamsson H, Simren M, Mattsson N, Jensen C, Agerforz P, Kilander A (2006) Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial. Aliment Pharmacol Ther 24(6):945","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10910_CR12","first-page":"e15022","volume":"13","author":"E Hendricks","year":"2021","unstructured":"Hendricks E, Ajmeri AN, Singh MM, Mongalo M, Goebel LJ (2021) A randomized open-label study of two methods of proton pump inhibitors discontinuation. Cureus 13(5):e15022","journal-title":"Cureus"},{"issue":"23","key":"10910_CR13","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","volume":"294","author":"S Dial","year":"2005","unstructured":"Dial S, Delaney JA, Barkun AN, Suissa S (2005) Use of gastric acid-suppressive agents and the risk of community-acquired clostridium difficile-associated disease. JAMA 294(23):2989","journal-title":"JAMA"},{"issue":"24","key":"10910_CR14","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","volume":"296","author":"YX Yang","year":"2006","unstructured":"Yang YX, Lewis JD, Epstein S, Metz DC (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296(24):2947","journal-title":"JAMA"},{"issue":"1","key":"10910_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cgh.2020.02.053","volume":"19","author":"M Simonov","year":"2021","unstructured":"Simonov M, Abel EA, Skanderson M, Masoud A, Hauser RG, Brandt CA, Wilson FP, Laine L (2021) Use of proton pump inhibitors increases risk of incident kidney stones. Clin Gastroenterol Hepatol 19(1):72","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10910_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","volume":"176","author":"B Lazarus","year":"2016","unstructured":"Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, Grams ME (2016) Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 176(2):238","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10910_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/phar.2235","volume":"39","author":"E Hart","year":"2019","unstructured":"Hart E, Dunn TE, Feuerstein S, Jacobs DM (2019) Proton pump inhibitors and risk of acute and chronic kidney disease: a retrospective cohort study. Pharmacotherapy 39(4):443","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10910_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","volume":"152","author":"DE Freedberg","year":"2017","unstructured":"Freedberg DE, Kim LS, Yang YX (2017) The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American gastroenterological association. Gastroenterology 152(4):706","journal-title":"Gastroenterology"},{"issue":"2","key":"10910_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.14309\/ajg.0000000000000061","volume":"114","author":"JE Kurlander","year":"2019","unstructured":"Kurlander JE, Kennedy JK, Rubenstein JH, Richardson CR, Krein SL, De Vries R, Saini SD (2019) Patients\u2019 perceptions of proton pump inhibitor risks and attempts at discontinuation: a national survey. Am J Gastroenterol 114(2):244","journal-title":"Am J Gastroenterol"},{"issue":"17","key":"10910_CR20","first-page":"2015","volume":"314","author":"ED Kantor","year":"1818","unstructured":"Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL (1818) Trends in prescription drug use among adults in the United States from 1999\u20132012. JAMA 314(17):2015","journal-title":"JAMA"},{"issue":"12","key":"10910_CR21","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/pds.5676","volume":"32","author":"E Bergin","year":"2023","unstructured":"Bergin E, Zylberberg HM, Lebwohl B, Freedberg DE (2023) Trends in use of proton pump inhibitors among adults in the United States from 1999 to 2018. Pharmacoepidemiol Drug Saf 32(12):1406","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10910_CR22","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases (2008) The burden of digestive diseases in the United States. Washington, DC: US Department of Health and Human Services, Public Health Service"},{"issue":"5","key":"10910_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3109\/00365521.2012.746395","volume":"48","author":"AB Lodrup","year":"2013","unstructured":"Lodrup AB, Reimer C, Bytzer P (2013) Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment. Scand J Gastroenterol 48(5):515","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"10910_CR24","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/ajg.2010.81","volume":"105","author":"A Niklasson","year":"2010","unstructured":"Niklasson A, Lindstrom L, Simren M, Lindberg G, Bjornsson E (2010) Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial. Am J Gastroenterol 105(7):1531","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10910_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/gut.39.5.649","volume":"39","author":"HL Waldum","year":"1996","unstructured":"Waldum HL, Arnestad JS, Brenna E, Eide I, Syversen U, Sandvik AK (1996) Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 39(5):649","journal-title":"Gut"},{"issue":"1","key":"10910_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1053\/j.gastro.2009.03.058","volume":"137","author":"C Reimer","year":"2009","unstructured":"Reimer C, Sondergaard B, Hilsted L, Bytzer P (2009) Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 137(1):80","journal-title":"Gastroenterology"},{"issue":"9","key":"10910_CR27","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1007\/s00464-014-4012-x","volume":"29","author":"B Robinson","year":"2015","unstructured":"Robinson B, Dunst CM, Cassera MA, Reavis KM, Sharata A, Swanstrom LL (2015) 20 years later: laparoscopic fundoplication durability. Surg Endosc 29(9):2520","journal-title":"Surg Endosc"},{"issue":"2","key":"10910_CR28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1572-0241.2007.01606.x","volume":"103","author":"BK Oelschlager","year":"2008","unstructured":"Oelschlager BK, Quiroga E, Parra JD, Cahill M, Polissar N, Pellegrini CA (2008) Long-term outcomes after laparoscopic antireflux surgery. Am J Gastroenterol 103(2):280","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10910_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jama.2017.10981","volume":"318","author":"J Maret-Ouda","year":"2017","unstructured":"Maret-Ouda J, Wahlin K, El-Serag HB, Lagergren J (2017) Association between laparoscopic antireflux surgery and recurrence of gastroesophageal reflux. JAMA 318(10):939","journal-title":"JAMA"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-024-10910-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-024-10910-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-024-10910-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T13:27:28Z","timestamp":1719926848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-024-10910-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10910"],"URL":"https:\/\/doi.org\/10.1007\/s00464-024-10910-y","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,6]]},"assertion":[{"value":"18 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Michael Johannes Pfl\u00fcger has\u00a0no conflicts of interest or financial ties to disclose.\u00a0Alisa Mae Coker receives honorarium for teaching, speaking, and consulting from Intuitive Surgical, and has received payment for expert testimony from MedPlace. Brenda Marie Zosa has no conflicts of interest. Gina Lynn Adrales is a Governance Committee member of SAGES, Opivoid task force Chair, and Quality\/Outcomes\/Safety committee member. Brett Colton Parker has received consulting fees and financial support by EndoGastric Solutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}